We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...

Released on Friday, February 7, the January jobs report showed resilience in the labor market with higher-than-expected wage ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

We ran that screen on Feb. 15 last year, using data as of the market close the previous day. Nvidia's (NVDA) stock has returned 80% from Feb. 14, 2024, through Tuesday, while the S&P 500 SPX has ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

On Super Bowl Sunday, many tuning into the big game saw a controversial ad from the telehealth company Hims & Hers. The ...

Even when measured against a more comprehensive list, momentum outdid all of its rivals in 2024 and is shaping up for a repeat in 2025, according to data shared with MarketWatch by Piper Sandler's ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

AstraZeneca’s share price has dropped recently on concerns relating to its Chinese operation, but this may have left the ...

We recently compiled a list of the Top 10 Must-See AI News Updates for Investors. In this article, we are going to take a ...

Birla Opus CEO Rakshit Hargave stated that the paint market is not as negative as some competitors have indicated. He noted the market is flat or slightly declining, but Birla Opus has gained market ...